Yahoo
NasdaqCM - Delayed Quote USD

Co-Diagnostics, Inc. (CODX)

1.1600 0.0000 (0.00%)
At close: September 4 at 4:00:01 PM EDT
1.1800 +0.0200 (+1.72%)
After hours: September 4 at 7:30:03 PM EDT
Chart Range Bar
Loading chart for CODX
  • Previous Close 1.1600
  • Open 1.1800
  • Bid 0.8352 x 200
  • Ask 13.0000 x 100
  • Day's Range 1.1408 - 1.1899
  • 52 Week Range 0.9400 - 46.5000
  • Volume 60,620
  • Avg. Volume 458,368
  • Market Cap (intraday) 8.098M
  • Beta (5Y Monthly) 2.86
  • PE Ratio (TTM) --
  • EPS (TTM) -25.8900
  • Earnings Date Nov 16, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.00

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.

co-dx.com

115

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CODX
77.12%
S&P 500 (^GSPC)
12.75%

1-Year Return

CODX
87.49%
S&P 500 (^GSPC)
18.71%

3-Year Return

CODX
96.78%
S&P 500 (^GSPC)
70.93%

5-Year Return

CODX
99.64%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 145.95k
Earnings -9.14M
Profit Margin -6,262.27%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-25M
-20M
-15M
-10M
-5M
0
-8000.0%
-6000.0%

Analyst Insights

View More

Analyst Price Targets

4.00
4.00 Average
1.1600 Current
4.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/26/2025
Analyst Maxim Group
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 1.5

Statistics

View More

Valuation Measures

Annual
As of 9/2/2026
  • Market Cap

    8.10M

  • Enterprise Value

    6.25M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.01

  • Price/Book (mrq)

    0.65

  • Enterprise Value/Revenue

    8.95

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -59.63%

  • Return on Equity (ttm)

    -174.77%

  • Revenue (ttm)

    721.39k

  • Net Income Avi to Common (ttm)

    -47.06M

  • Diluted EPS (ttm)

    -25.8900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.65M

  • Total Debt/Equity (mrq)

    14.15%

  • Levered Free Cash Flow (ttm)

    -17.49M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.1600 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: